Richard M. Keeling

1.2k total citations
15 papers, 999 citations indexed

About

Richard M. Keeling is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Richard M. Keeling has authored 15 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Immunology. Recurrent topics in Richard M. Keeling's work include Muscle Physiology and Disorders (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Exercise and Physiological Responses (4 papers). Richard M. Keeling is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Exercise and Physiological Responses (4 papers). Richard M. Keeling collaborates with scholars based in United States. Richard M. Keeling's co-authors include Anne H. Cross, Anne M. Connolly, Thomas P. Misko, Paul T. Golumbek, Pamela T. Manning, Robert E. Schmidt, Manuel San, Joshua R. Sanes, Ricki Robinson and Michael Chez and has published in prestigious journals such as Journal of Clinical Investigation, Development and Biological Psychiatry.

In The Last Decade

Richard M. Keeling

15 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard M. Keeling United States	14	402	258	193	169	165	15	999
Carola Krüger Germany	16	518 1.3×	191 0.7×	171 0.9×	88 0.5×	36 0.2×	21	1.5k
Richard Fairless Germany	23	518 1.3×	133 0.5×	126 0.7×	102 0.6×	57 0.3×	39	1.4k
Jie Deng China	19	688 1.7×	129 0.5×	99 0.5×	377 2.2×	186 1.1×	42	1.5k
Asha Bhakar Canada	13	968 2.4×	232 0.9×	123 0.6×	331 2.0×	150 0.9×	13	1.6k
Keyi Yang United States	24	761 1.9×	66 0.3×	92 0.5×	204 1.2×	43 0.3×	45	1.6k
Roberto Elizondo‐Vega Chile	21	444 1.1×	152 0.6×	261 1.4×	55 0.3×	96 0.6×	33	1.3k
Colin P. Glover United Kingdom	17	507 1.3×	65 0.3×	86 0.4×	142 0.8×	127 0.8×	26	967
David W. Hampton United Kingdom	19	437 1.1×	123 0.5×	191 1.0×	77 0.5×	89 0.5×	27	1.3k
Eric Maubert France	27	531 1.3×	99 0.4×	115 0.6×	69 0.4×	51 0.3×	52	1.7k
Miriam González‐Gómez Spain	20	471 1.2×	66 0.3×	163 0.8×	233 1.4×	45 0.3×	57	1.2k

Countries citing papers authored by Richard M. Keeling

Since Specialization

Citations

This map shows the geographic impact of Richard M. Keeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Keeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Keeling more than expected).

Fields of papers citing papers by Richard M. Keeling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Keeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Keeling. The network helps show where Richard M. Keeling may publish in the future.

Co-authorship network of co-authors of Richard M. Keeling

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Keeling. A scholar is included among the top collaborators of Richard M. Keeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Keeling. Richard M. Keeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bibee, Kristin, James Kain Ching, Jon N. Marsh, et al.. (2014). Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. The FASEB Journal. 28(5). 2047–2061. 65 indexed citations

Golumbek, Paul T., Richard M. Keeling, & Anne M. Connolly. (2007). Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Neuromuscular Disorders. 17(5). 376–384. 23 indexed citations

Golumbek, Paul T., Richard M. Keeling, & Anne M. Connolly. (2007). RAG2 gene knockout in mice causes fatigue. Muscle & Nerve. 36(4). 471–476. 6 indexed citations

Keeling, Richard M., et al.. (2006). Weekly oral prednisolone improves survival and strength in male mdx mice. Muscle & Nerve. 35(1). 43–48. 57 indexed citations

Connolly, Anne M., Michael Chez, Richard M. Keeling, et al.. (2005). Brain-Derived Neurotrophic Factor and Autoantibodies to Neural Antigens in Sera of Children with Autistic Spectrum Disorders, Landau-Kleffner Syndrome, and Epilepsy. Biological Psychiatry. 59(4). 354–363. 201 indexed citations

Connolly, Anne M., et al.. (2002). Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin α2-deficient mice. Journal of Neuroimmunology. 127(1-2). 80–87. 24 indexed citations

Connolly, Anne M., et al.. (2001). Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice. Neuromuscular Disorders. 11(8). 703–712. 112 indexed citations

Cross, Anne H., Manuel San, Michael Stern, et al.. (2000). A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 107(1). 21–28. 33 indexed citations

Cross, Anne H., Manuel San, Richard M. Keeling, & Robert W. Karr. (1999). CTLA-4-Fc treatment of ongoing EAE improves recovery, but has no effect upon relapse rate.. Journal of Neuroimmunology. 96(2). 144–147. 13 indexed citations

10.

Cross, Anne H., Jeri‐Anne Lyons, Manuel San, et al.. (1999). T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis. European Journal of Immunology. 29(10). 3140–3147. 25 indexed citations

11.

Cross, Anne H., Pamela T. Manning, Richard M. Keeling, Robert E. Schmidt, & Thomas P. Misko. (1998). Peroxynitrite formation within the central nervous system in active multiple sclerosis. Journal of Neuroimmunology. 88(1-2). 45–56. 166 indexed citations

12.

Hewett, Sandra J., et al.. (1996). Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. Journal of Neuroimmunology. 64(2). 201–208. 25 indexed citations

13.

Cross, Anne H., Richard M. Keeling, Salil Goorha, et al.. (1996). Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 71(1-2). 145–153. 81 indexed citations

14.

Cross, Anne H., K S Giacoletto, Robert J. Evans, et al.. (1995). Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.. Journal of Clinical Investigation. 95(6). 2783–2789. 133 indexed citations

15.

Kirk, David, et al.. (1991). Genetic and cytological control of the asymmetric divisions that pattern the Volvox embryo. Development. 113(Supplement_1). 67–82. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact